[2026 update] Travelling with an injectable: documentation and practicalities
The arithmetic in post #25 is right; the assumption feeding it is the part to check.
Temperature-controlled material and long-haul travel is a practical problem with practical solutions, none of which are on the packaging.
Post #34 and I disagree about the size of the effect, not about the direction.
Summaries lag badly in this area. Where a decision matters, read the current official document rather than a page about it, including this one.
I would want the raw data before agreeing with my own summary of it.
Taking post #43 at face value and following it one step further.
The most useful thing anyone can add to a thin regional thread is what the official source says and where it is, rather than what happened to them.
Not the answer, but possibly the question that gets there.
Building on post #65 rather than restating it.
Both are useful and they are different contributions. A first-hand account and a citation answer different halves of the question.
Adding a source would improve this post and I do not have one to hand.
I read post #74 twice before replying, because I had assumed the opposite.
Summaries lag badly in this area. Where a decision matters, read the current official document rather than a page about it, including this one.
I would want to see it done twice before believing it once.
Summaries lag badly in this area. Where a decision matters, read the current official document rather than a page about it, including this one.
That is a description of practice, not a recommendation of it.
That is consistent with mine, for whatever one more account is worth.
Read the full topic (112 posts)
Suggested topics
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Personal import allowances, compared — a second dataset
Personal import allowances, compared — a second dataset — setting out what I have, and where I think it stops being reliable. Posting a small dataset on Personal import allowances. It is mine, it is…
|
+124 | 132 | 9.2k | 2mo |
|
What changed in 2026, by region — does this still hold?
What changed in 2026, by region — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Documenting an access outcome, dated, because everything in…
|
+20 | 25 | 50k | 1d |
|
Prescription portability between countries
Prescription portability between countries — setting out what I have, and where I think it stops being reliable. Asking about prescription portability between countries directly, because I have read four…
|
+104 | 114 | 6.1k | 3h |
|
What changed in 2026, by region
What changed in 2026, by region — that is the question, and I have not found it answered plainly anywhere I have looked. Documenting an access outcome, dated, because everything in this category expires. As…
|
+110 | 122 | 1.4k | 18mo |
|
[2026 update] Availability by country, dated, with primary sources
On the subject in the title: Availability by country, dated, with primary sources Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category expires. As…
|
+40 | 45 | 14k | 4mo |
Related topics — sharing the tags telehealth, EMA, MHRA
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Travelling with an injectable: documentation and practicalities
Posting this under the heading it deserves: Travelling with an injectable: documentation and practicalities Everything below is what sits behind that. Documenting a stated criterion rather than an outcome,…
|
+37 | 42 | 2.1k | 1d |
|
Enforcement priorities versus written rules — does this still hold?
Enforcement priorities versus written rules — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. Asking what a regulator's document actually says,…
|
+36 | 40 | 37k | 11mo |
|
Coverage in the US: a map of the usual obstacles
Coverage in the US: a map of the usual obstacles — setting out what I have, and where I think it stops being reliable. Trying to establish the boundary conditions on coverage. The general claim is fine; I…
|
+46 | 50 | 7.9k | 5mo |
|
Coming back to: Getting a referral rather than a refusal
Posting this under the heading it deserves: Getting a referral rather than a refusal Everything below is what sits behind that. Working notes on Getting a referral rather than a conclusion. I would rather…
|
+69 | 74 | 1.7k | 13mo |
|
Pharmaceutical compounding rules, summarised from primary sources
Pharmaceutical compounding rules, summarised from primary sources — setting out what I have, and where I think it stops being reliable. Asking what a regulator's document actually says, since the summaries of…
|
+135 | 163 | 46k | 17mo |